Helix Biopharma Corp.
HBPCF
$0.60
$0.011.70%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -62.48% | 742.97% | -79.10% | 51.49% | 475.92% |
| Total Receivables | -1.28% | -8.91% | -34.02% | -38.91% | 33.89% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 32.16% | 38.91% | -56.76% | 2.06% | 149.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -52.98% | 431.98% | -72.50% | 30.39% | 253.48% |
|
|
|||||
| Total Current Assets | -52.98% | 431.98% | -72.50% | 30.39% | 253.48% |
| Net Property, Plant & Equipment | -61.07% | 101.54% | -71.98% | -6.07% | -13.03% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -100.00% | 0.00% | 0.00% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -52.86% | 421.41% | -72.44% | 29.38% | 224.04% |
|
|
|||||
| Total Accounts Payable | -49.57% | 260.68% | 14.54% | -21.95% | 216.73% |
| Total Accrued Expenses | -21.29% | 0.07% | 8.17% | 97.33% | 32.60% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.13% | 22.44% | 11.62% | 4.39% | 142.96% |
|
|
|||||
| Total Current Liabilities | 11.13% | 22.44% | 11.62% | 4.39% | 142.96% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.13% | 22.44% | 11.62% | 4.39% | 142.96% |
|
|
|||||
| Common Stock & APIC | 5.29% | -2.22% | -1.13% | 1.16% | -1.82% |
| Retained Earnings | -5.50% | 3.09% | 0.24% | -2.05% | 1.78% |
| Treasury Stock & Other | -15.49% | -12.35% | 11.79% | 85.62% | -2.38% |
| Total Common Equity | -7,578.63% | 98.66% | -1,401.23% | 75.11% | -35.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7,578.63% | 98.66% | -1,401.23% | 75.11% | -35.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7,578.63% | 98.66% | -1,401.23% | 75.11% | -35.28% |
|
|
|||||